Oral Oncology

Article	Citations
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review	274
Surgical treatment of benign parotid gland tumors: From functional surgery to personalized surgery	93
Comment on, “Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapy”	78
Sarcomatoid salivary duct carcinoma of Parotid: A case report and Review of the Literature	64
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?	59
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review	54
A rare case of recurrent calcifying epithelial odontogenic tumor in an adolescent patient: Case report and review of literature	53
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma	47
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions	42
Oncologic significance of the lateral margin in buccal cancer	41
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry	39
Addressing knowledge gaps in HPV-related oropharyngeal cancer prevention: A call for action	38
Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain	38
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival	37
Does lymphovascular invasion predict survival in oral cancer? A population-based analysis	36
Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients	33
The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads	32
Prognostic nomograms for nasopharyngeal carcinoma with nodal features and potential indication for N staging system: Validation and comparison of seven N stage schemes	32
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”	31
Does identification of determinants that delay adjuvant treatment and discussing the benefits of adjuvant treatment with patients create an impact?	29
Undifferentiated small round cell sarcoma of the parapharyngeal space in a 4.5-year-old patient:A rare case report	29
Omitting elective neck dissection in cT1/2N0 oral squamous cell carcinoma with sentinel lymph node metastasis: A prospective study	29
Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers	29
Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer	29
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma	28

The spiral ladder technique of facial nerve trunk identification during parotidectomy: A convenient roadmap for the beginners	28
Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report	28
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population	27
Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients	27
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	26
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients	26
A rare case of squamous cell carcinoma of the gingiva: A diagnostic challenge	25
Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis	25
Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma	25
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis	24
Risk, prevention, screening and management of carotid artery stenosis in head & neck cancer patients—An evidence based review	24
Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral/oropharyngeal carcinoma	24
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer	24
Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: Clinicopathological characterization and whole-exome sequencing insights	24
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge	24
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”	24
Required time for pre-oncological dental management – A rapid review of the literature	24
Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma	23
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study	23
Author’s reply to comment on “awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?”	23
Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway	23
Letter to the Editor: “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral Cancer”	22
Need for clarification on pathological tumor size for lip and oral cavity cancers with size ≤ 2 cm and depth of Invasion > 10 mm: A letter to the editor	22
Lower cranial nerve palsy after hypofractionated radiotherapy in a laryngeal cancer patient: A letter to the editor	22
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”	22
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection	22
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study	21
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer	21
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies	21
Survival and functional outcomes after total glossectomy with total laryngectomy: Case series from a high-volume tertiary institution	21
Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma – Pooled analysis of two randomized trials	20
Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort	20
Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma	20
Is the current oropharyngeal cancer T classification adequate in the era of HPV and transoral robotic surgery?	20
Overestimated risk of transformation in oral lichen planus	20
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective study	19
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma	19
Role of surgical margins in transoral robotic surgery: A question yet to be answered	19
Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma	19
Oral cancer histopathology images and artificial intelligence: A pathologist's perspective	18
Tongue reconstruction by submental flap	18
Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study	18
Noninvasive genomic profiling of somatic mutations in oral cavity cancers	18
Commentary on, “Thyroid volumes after intensity-modulated radiotherapy as predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study”	17
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma	17
Synchronous adenoid cystic carcinoma in the submandibular gland and tongue: A rare case report	17
Field cancerization revisited in purview of quantum entanglement: Delving into the unexplored	17
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study	17
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells	17
Scales to graduate oral mucositis: What are the limitations?	17

Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain	17
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes	17
TransOral UltraSonic surgery (TOUSS) for oral cavity, oropharyngeal and supraglottic malignancy: A prospective study of feasibility, safety, margins, functional and survival outcomes	17
Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer	17
A brief overview of 100 best-cited papers on oral submucous fibrosis in Oral Oncology	17
Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma	16
Quality of life in patients with oral squamous cell carcinoma: A critical assessment tool, sadly ignored!	16
What's ahead for complete responders following NACT?	16
Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer	16
The challenging diagnosis of low-grade myofibroblastic sarcoma: A case report and literature update	16
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review	16
Extraskeletal Ewing’s sarcoma of supraglottis: A rare case report	16
Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma	16
Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology	16
Diagnostic tips for parotid lymphoma	15
P-225 A comparison of clinical and pathological TNM staging in a COVID-19 era	15
Transoral endoscopic thyroidectomy using a self-retaining retractor as an alternative to carbon dioxide gas insufflation: A comparative analysis of 131 cases	15
Malignant melanoma in situ of the palate: Radical treatment or “watch and wait”? An update reporting an adverse outcome	15
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders	15
A case of metastatic NUT carcinoma of the nasal cavity	15
Editorial Board/Aims & Scope	15
A rare combined motley variety of odontogenic tumors – Hybrid lesion or a new entity?	15
Patient specific follow-up to monitor the risk of malignant transformation on oral mucosa	15
P-54 Response rate after chemoembolization with followed radiation therapy in patients with locally advanced nasopharyngeal carcinoma	15
Oral epithelioid rhabdomyosarcoma: Report of a rare case and literature review of a distinct variant of rhabdomyosarcoma	15
COVID-19 pandemic and lock-down protocols: Impact in an indian tertiary cancer center	15
Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma	15
8 “S” of obturators in Head and Neck Cancer Rehabilitation during COVID-19 pandemic	15
Editorial Board/Aims & Scope	15
Atypical metastases highlight the true potential of ctDNA liquid biopsies for cancer monitoring	15
Methodological challenges in identifying histological prognostic markers for squamous cell carcinoma of the lip, mouth, and oropharynx	14
Mycobiota profile of oral fungal infections in head and neck cancer patients receiving radiotherapy: A 6-year retrospective MALDI-TOF mass spectrometry study	14
Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?	14
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer	14
Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study	14
Comment on “Predictors of prolonged treatment time intervals in oral cavity cancer”	14
The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study	14
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2	14
Reply to: Comment on “Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems”	14
ERα: A biomarker and treatment target for oropharyngeal cancer?	13
Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions	13
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies	13
Sentinel lymph node biopsy-does the building evidence tick all the boxes to make it a standard of care as of today?	13
P-24 Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach	13
Oral field cancerization: A critical appraisal	13
O4.2 Early detection of recurrent HPV-positive HNSCC by ctDNA analysis	13
A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis	13
CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma	13
Editorial Board/Aims & Scope	13
Extra imaging beyond NCCN surveillance guidelines is cost effective for HPV− but not HPV+ oropharyngeal cancer	13
Nasopharyngeal Brush Epstein Barr Viral DNA in the Detection of Locally Recurrent Nasopharyngeal Carcinoma	13
Salvage Treatment in Isolated Regional Recurrent Head and Neck Squamous Cell Carcinoma	13
Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer	13
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer	13
Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?	13
Hypofractionated chemoradiation (2.75 Gy per fraction) in Head and Neck Cancer: Extreme caution required	13
Editorial Board/Aims & Scope	13
O5.1 Deciphering knowledge and opinions of HPV and HPV vaccination for facilitation of point-of-care vaccination	13
Hypopharyngeal dedifferentiated liposarcoma: What we have learned so far	13
Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma	13
A case of liposarcoma with osteolysis of the maxilla as the first symptom and review of the literature	12
P-165 Opportunities for surgical treatment of elderly patients with head and neck tumors	12
P28 Head and neck cancer cells differentiate resembling their tissue of origin	12
P-67 Dosimetric results and NTCP models comparison between VMAT and IMPT for nasopharyngeal cancer patients	12
Editorial Board/Aims & Scope	12
Editorial Board/Aims & Scope	12
P-242 Laryngeal metastasis from lung cancer: A case report	12
Transoral surgery may be less cost effective than radiotherapy	12
P-115 The potential of panel-based gene expression analysis in the identification of head and neck cutaneous squamous cell carcinoma with high risk of lymph node metastasis	12
P-238 Nasosinusal Lymphoepithelial carcinoma	12
P-261 Laryngeal Dysplasia: A Systematic Review of Prognostic Factors in the Development of Malignancy	12
Regarding to “Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?”	12
Ultrasound Scan Pre-Operative Localization of Recurrent Thyroid Cancer – Technique and Early Outcomes	12
P-247 Neck Mass in a Young Adult – An Atypical Case of Lymphoma solved with biopsy	12
P-16 Evaluation of two ratios predicting natural killer cell function in nasopharyngeal and other head and neck cancers patients leading towards better prognosis	11
Is locally advanced head and neck cancer ‘increasing’ in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share	11
P-50 Oropharyngeal Cancer; Survival of the Elderly	11
P07 The tumor immune microenvironment and its association with progression free survival in patients with oropharyngeal squamous cell carcinoma	11
P-49 Could organ sparing radiotherapy for larynx cancer have prevented World War I?	11
P-40 Radiotherapy with curative intent in head and neck cancer – Experience from a tertiary care center	11

Editorial Board/Aims & Scope	11
P-31 Oral Squamous Cell Carcinoma in Patients with 45 Years or Under – 7 Years Experience of an Oral Medicine Centre	11
The positive yield of multidisciplinary team decisions in a high volume head and neck center after those made in its preferred partner: An example of enhanced quality of care	11
P-217 Evaluation of the percutaneous endoscopic gastrostomy in situ rates following completion of radical treatment in patients with oropharyngeal squamous cell carcinomas: a single centre experience	11
P-117 Oncological outcomes of patients with parotid metastasis of skin malignancies	11
P-25 Socioeconomic inequality in survival after oropharynx cancer according to HPV-status: the impact of stage, smoking and comorbidity – a nationwide study from DAHANCA	11
P-111 Necrotizing Sialometaplasia: Differential diagnosis and treatment of a malignant masquerade	11
P-239 The Impact of the Introduction of a Triage Risk Calculator to the NHS Lothian (Scotland) Head and Neck Service	11
P-109 Androgen deprivation therapy for salivary gland tumours: experience of a single institution	11
Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help	11
P19 Detection of HPV16 cell-free DNA in liquid biopsies for early detection of HPV-OPC	11
P-164 Transoral laser resection of early supraglottic tumours, comparative quality of life study and cost benefit versus horizontal supraglottic laryngectomy	11
P-41 Pattern of failure in oropharyngeal cancer patients treated with IMRT: comparison of two different CTV expansion modalities	11
P-66 Locally advanced cancers of larynx or hypopharynx: Real world management outcomes and prognostic factors in the IMRT era at South Yorkshire cancer network, UK	11
P-105 Sternocleidomastoid Rotational Flap for Recurrent Parotid Malignancy	11
P-169 The Incidence of Thyroid Gland Invasion in Advanced Stage Laryngeal Cancers with Emphasis on Risk Factors and Its Impact on Survival	11
The role of precision medicine in head and neck cancer: A systematic study of ongoing clinical trials	10
P-158 Outcomes of submental flap reconstruction fororal defects in surgical treatment of oral cancer	10
The usefulness of hybrid platform meetings for research ethics committees review meetings	10
P-144 Tongue Carcinoma Case Treated with a Pull Through Procedure Approach with Better Esthetic Outcomes	10
An unsolved dilemma in the reliability of virtual planning in mandibular reconstruction surgery: Short communication	10
P-193 Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma	10
P-195 A two-centre review of the management of cytologically suspicious thyroid nodules for Malignancy (Thy 4)	10
P-22 Artifact reduction in head and neck CT images using polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyphenylsulfone (PPSU) and polyether (PE) polymer implants in mandible reconstruct	10
P-126 Benefits of reconstruction of oral cavity organs in oncological patients with reinnervated free flaps	10
P-86 Tumor Recurrence on Pectoralis Major Myocutaneous Flap	10
P-140 Clinical outcomes following pharyngolaryngectomy reconstruction: a 20-year single centre study	10
P-130 The effect of fibrin sealant glue in reducing post-operative collections following parotidectomy	10
Primary Ewing's sarcoma (ES)/peripheral primitive neuroectodermal tumor (pPNET) of the tongue in a child: A case report	10
Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer	10
P-79 Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy	10
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]	10
P-91 Correlation of outcomes with prognostic factors in early node negative and node positive Oral cavity Squamous Cell Carcinoma patients	10
Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders – Reply	10
P-72 Hypofractionated, Dose redistributed RAdiotherapy for head and neck squamous cell carcinoma (HYDRA)	10
Targeting cancer associated fibroblasts – A TGF-β based immunotherapy for head and neck squamous cell carcinoma	10
P-99 SUCNR1 and SDHA Gene Expression in Tumoral Tissue Is Associated with Locoregional Disease-Free Survival	10
P-190 Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials	10
P-39 Locoregional failures after radical radiotherapy	10
O5.2 Nodal involvement determines the initial quantity of circulating free HPV16 DNA in patients with HPV-related oropharyngeal cancer	10
P-167 Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Elective Neck Dissection	10
P-128 Long-term follow up of oral oncology patients after mandibular reconstruction	10
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study	9
A call for the universal acceptance of the modified Milan system for reporting salivary gland cytopathology	9
Oral leukoplakia in adolescents: Report of a rare case and review of the literature	9
The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis	9
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database	9
Accelerated implementation of teleconsultation services for the monitoring of oral potentially malignant disorders as a result of the COVID-19 pandemic	9
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study	9
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma	9
Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients	9
Primary and secondary ameloblastic carcinoma can be classified into not distinct categories but a single entity: A comparative study	9
Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: A systematic review and meta-analysis	9
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site	9
Global research on oral cancer: A bibliometric analysis based on 82 highly cited publications from 2014 to 2024	9
Objective evaluation of orbito-zygomatic reconstruction with scapular tip free flaps to restore facial projection and orbital volume	9
Invasive oral squamous cell carcinoma of maxillary alveolus in a Nicobari tribal woman after 17 years of tobacco cessation – A case report	9
Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma	9
Survival impact of increasing time to IMRT initiation following induction chemotherapy in nasopharyngeal carcinoma: A propensity score-matched analysis	9
P-257 Cervical lymphadenopathy following COVID-19 vaccine: Clinical characteristics and implications for head and neck cancer services	9
Femoral artery-nourished anteromedial thigh flap: A new perspective in oral and maxillofacial defect reconstruction	9
The effect of treatment package time on locally advanced oral cavity cancer outcomes	9
Bite me: Can active biting during trismus therapy improve mouth opening in head and neck cancer patients?	9
Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs	9
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study	9
Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!	9
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma	9
Preoperative prediction model in salvage surgery for oral cavity squamous cell carcinoma: Precision before Assertion	9
A rare case of extensive gingival lymphatic malformation	9
Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment	8
Is Age ≥ 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study	8
The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology	8
Clinical features and prognostic factors of nasopharyngeal carcinoma with brain metastases	8
The role of microbiota in nasopharyngeal cancer: Where do we stand?	8
Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma	8
Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models	8
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?	8
Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma	8
Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?	8
Functional outcomes and complications of total glossectomy with laryngeal preservation and flap reconstruction: A systematic review and meta-analysis	8
Neoadjuvant chemotherapy combined with transoral robotic surgery for stage III and IV laryngeal and hypopharyngeal carcinomas	8
A case report on a nasal and oral cavity involving large solitary fibrous tumor and comprehensive review of case literature	8
Effects of personalized swallowing rehabilitation in patients with oral cancer after free flap transplantation: A cluster randomized controlled trial	8
Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors	8
Function-preserving intracapsular enucleation of brachial plexus schwannomas: Is it safe and effective?	8
Margin-to-depth ratio as an independent prognostic factor in resected oral cavity squamous cell carcinoma: A nationwide cohort study	8
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study	8
Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer	8
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis	8
Results of CO2 laser surgery in laryngeal papillomatosis	8
Accuracy and outcomes of virtual surgical planning and 3D-printed guides for osseous free flap reconstruction of mandibular osteoradionecrosis	8
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment	8
MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma	8
Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease	8
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis	7